在第二代药物洗脱支架时代，弥漫性长冠状动脉疾病仍是经皮冠状动脉介入治疗的障碍吗？ - Suppr

Diffuse Long Coronary Artery Disease is Still an Obstacle for Percutaneous Coronary Intervention in the Second-Generation Drug-Eluting Stent Era?

作者信息

Oh Pyung Chun, Han Seung Hwan

机构信息

Division of Cardiology, Department of Internal Medicine, Gachon University College of Medicine, Gachon University Gil Medical Center, Incheon, Korea.

出版信息

Korean Circ J. 2019 Aug;49(8):721-723. doi: 10.4070/kcj.2019.0150. Epub 2019 Jun 19.

DOI:10.4070/kcj.2019.0150

PMID:31347314

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6675689/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1510/6675689/9f55ca9cf10f/kcj-49-721-g001.jpg

相似文献

Diffuse Long Coronary Artery Disease is Still an Obstacle for Percutaneous Coronary Intervention in the Second-Generation Drug-Eluting Stent Era?在第二代药物洗脱支架时代，弥漫性长冠状动脉疾病仍是经皮冠状动脉介入治疗的障碍吗？

Korean Circ J. 2019 Aug;49(8):721-723. doi: 10.4070/kcj.2019.0150. Epub 2019 Jun 19.

Prognostic Effects of Treatment Strategies for Left Main Versus Non-Left Main Bifurcation Percutaneous Coronary Intervention With Current-Generation Drug-Eluting Stent.当前代药物洗脱支架经皮冠状动脉介入治疗左主干与非左主干分叉病变的治疗策略的预后影响。

Circ Cardiovasc Interv. 2020 Feb;13(2):e008543. doi: 10.1161/CIRCINTERVENTIONS.119.008543. Epub 2020 Feb 7.

Outcomes With Intravascular Ultrasound-Guided Stent Implantation: A Meta-Analysis of Randomized Trials in the Era of Drug-Eluting Stents.血管内超声指导下支架植入的结果：药物洗脱支架时代的随机试验荟萃分析。

Circ Cardiovasc Interv. 2016 Apr;9(4):e003700. doi: 10.1161/CIRCINTERVENTIONS.116.003700. Epub 2016 Mar 15.

Comparison between diabetic and non-diabetic patients after successful percutaneous coronary intervention for chronic total occlusions in the drug-eluting stent era.药物洗脱支架时代成功进行经皮冠状动脉介入治疗慢性完全闭塞病变后糖尿病患者与非糖尿病患者的比较。

Rev Port Cardiol. 2015 Apr;34(4):263-70. doi: 10.1016/j.repc.2014.10.009. Epub 2015 Apr 1.

Percutaneous Coronary Intervention of Left Main Disease: Pre- and Post-EXCEL (Evaluation of XIENCE Everolimus Eluting Stent Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization) and NOBLE (Nordic-Baltic-British Left Main Revascularization Study) Era.左主干疾病的经皮冠状动脉介入治疗：EXCEL（评价依维莫司洗脱支架 XIENCE 与冠状动脉旁路移植术治疗左主干血运重建效果）和 NOBLE（北欧-波罗的海-英国左主干血运重建研究）时代之前和之后。

Circ Cardiovasc Interv. 2017 Jun;10(6). doi: 10.1161/CIRCINTERVENTIONS.117.004792.

Impact of everolimus-eluting stent length on long-term clinical outcomes of percutaneous coronary intervention.依维莫司洗脱支架长度对经皮冠状动脉介入治疗长期临床结局的影响。

J Cardiol. 2018 May;71(5):444-451. doi: 10.1016/j.jjcc.2017.10.011. Epub 2017 Nov 22.

Efficacy and Safety of Percutaneous Coronary Intervention for Elderly Patients in the Second-Generation Drug-Eluting Stent Era: The SHINANO Registry.第二代药物洗脱支架时代老年患者经皮冠状动脉介入治疗的疗效与安全性：信浓注册研究

Angiology. 2017 Sep;68(8):688-697. doi: 10.1177/0003319716679341. Epub 2016 Nov 16.

Long-term comparative analysis from an all-comer cohort of coronary patients treated using first- and second-generation drug-eluting stents.对使用第一代和第二代药物洗脱支架治疗的所有冠心病患者队列进行的长期比较分析。

J Invasive Cardiol. 2014 Aug;26(8):378-84.

Risk Factors and Long-Term Clinical Outcomes of Second-Generation Drug-Eluting Stent Thrombosis.第二代药物洗脱支架血栓形成的危险因素和长期临床结局。

Circ Cardiovasc Interv. 2019 Jun;12(6):e007822. doi: 10.1161/CIRCINTERVENTIONS.119.007822. Epub 2019 Jun 10.

Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting in Patients With Left Main Coronary Artery Stenosis: A Systematic Review and Meta-analysis.经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗左主干狭窄患者的比较：系统评价和荟萃分析。

JAMA Cardiol. 2017 Oct 1;2(10):1079-1088. doi: 10.1001/jamacardio.2017.2895.

引用本文的文献

Ultrasonic flow ratio measured immediately after successful rotational atherectomy with stent implantation predicts major adverse cardiovascular events.在成功进行旋磨术并植入支架后立即测量的超声血流比率可预测主要不良心血管事件。

Front Cardiovasc Med. 2025 May 7;12:1418587. doi: 10.3389/fcvm.2025.1418587. eCollection 2025.

Long-term safety and performance of the BioMime Morph sirolimus-eluting coronary stent system for very long coronary lesions in real-world settings.生物模拟形态西罗莫司洗脱冠状动脉支架系统在真实世界中用于超长冠状动脉病变的长期安全性和性能

AsiaIntervention. 2025 Mar 20;11(1):14-25. doi: 10.4244/AIJ-D-24-00008. eCollection 2025 Mar.

One-Year Outcomes of Long Coronary Drug-Eluting Stents (≥40 MM) in Patients With Diffuse Coronary Artery Disease: Findings From a Tertiary Care Hospital in North India.长冠状动脉药物洗脱支架（≥40毫米）治疗弥漫性冠状动脉疾病患者的一年结局：来自印度北部一家三级护理医院的研究结果。

Cureus. 2024 May 3;16(5):e59611. doi: 10.7759/cureus.59611. eCollection 2024 May.

Acute and one-year clinical outcomes of pre-stenting intravascular ultrasound: a patient-level meta-analysis of randomised clinical trials.经皮血管内超声预支架置入术的急性和一年临床结果：随机临床试验的患者水平荟萃分析。

EuroIntervention. 2021 Jun 25;17(3):202-211. doi: 10.4244/EIJ-D-20-00276.

本文引用的文献

Effectiveness and Safety of Zotarolimus-Eluting Stent (Resolute™ Integrity) in Patients with Diffuse Long Coronary Artery Disease.佐他莫司洗脱支架（Resolute™ Integrity）在弥漫性长冠状动脉疾病患者中的有效性和安全性。

Korean Circ J. 2019 Aug;49(8):709-720. doi: 10.4070/kcj.2019.0018. Epub 2019 May 15.

The Practice Pattern of Percutaneous Coronary Intervention in Korea: Based on Year 2014 Cohort of Korean Percutaneous Coronary Intervention (K-PCI) Registry.韩国经皮冠状动脉介入治疗的实践模式：基于2014年韩国经皮冠状动脉介入治疗（K-PCI）注册研究队列。

Korean Circ J. 2017 May;47(3):320-327. doi: 10.4070/kcj.2017.0070. Epub 2017 May 25.

Zotarolimus-eluting Resolute Integrity versus everolimus-eluting Xience Xpedition stents in the management of very long (>30mm) de novo coronary artery stenosis.佐他莫司洗脱Resolute Integrity支架与依维莫司洗脱Xience Xpedition支架治疗超长（>30mm）原发冠状动脉狭窄的对比研究

Cardiovasc Revasc Med. 2017 Apr-May;18(3):160-164. doi: 10.1016/j.carrev.2016.12.007. Epub 2016 Dec 15.

Effect of Intravascular Ultrasound-Guided vs Angiography-Guided Everolimus-Eluting Stent Implantation: The IVUS-XPL Randomized Clinical Trial.血管内超声指导与血管造影指导依维莫司洗脱支架置入的效果：IVUS-XPL 随机临床试验。

JAMA. 2015 Nov 24;314(20):2155-63. doi: 10.1001/jama.2015.15454.

Prospective study to evaluate safety and efficacy of Zotarolimus Eluting Stent (PSEZES) in patients with long coronary artery lesions.评估佐他莫司洗脱支架（PSEZES）在长冠状动脉病变患者中的安全性和有效性的前瞻性研究。

Indian Heart J. 2015 May-Jun;67(3):233-8. doi: 10.1016/j.ihj.2015.03.014. Epub 2015 May 13.

4-year clinical outcomes and predictors of repeat revascularization in patients treated with new-generation drug-eluting stents: a report from the RESOLUTE All-Comers trial (A Randomized Comparison of a Zotarolimus-Eluting Stent With an Everolimus-Eluting Stent for Percutaneous Coronary Intervention).新型药物洗脱支架治疗患者的 4 年临床结果和再次血运重建的预测因素：RESOLUTE 所有患者试验的报告（一种新型佐他莫司洗脱支架与依维莫司洗脱支架经皮冠状动脉介入治疗的随机比较）。

J Am Coll Cardiol. 2014 Apr 29;63(16):1617-25. doi: 10.1016/j.jacc.2013.12.036. Epub 2014 Feb 13.

One-year outcomes of percutaneous coronary intervention with the 38-mm Resolute zotarolimus-eluting stent.38mm 雷帕霉素洗脱钴基合金 Resolute 支架经皮冠状动脉介入治疗一年的结果。

Am J Cardiol. 2013 Nov 1;112(9):1335-41. doi: 10.1016/j.amjcard.2013.06.012. Epub 2013 Aug 14.

Lesion length impacts long term outcomes of drug-eluting stents and bare metal stents differently.病变长度对药物洗脱支架和裸金属支架的长期结果的影响不同。

PLoS One. 2013;8(1):e53207. doi: 10.1371/journal.pone.0053207. Epub 2013 Jan 11.

Comparison of resolute zotarolimus-eluting stents and sirolimus-eluting stents in patients with de novo long coronary artery lesions: a randomized LONG-DES IV trial.比较新型的佐他莫司洗脱支架与西罗莫司洗脱支架在治疗初发长段冠状动脉病变患者中的疗效：一项随机 LONG-DES IV 试验。

Circ Cardiovasc Interv. 2012 Oct;5(5):633-40. doi: 10.1161/CIRCINTERVENTIONS.111.965673. Epub 2012 Oct 9.

Clinical, physiologic, anatomic and procedural factors predictive of restenosis after percutaneous transluminal coronary angioplasty.经皮腔内冠状动脉成形术后再狭窄的临床、生理、解剖及操作因素预测

J Am Coll Cardiol. 1991 Aug;18(2):368-76. doi: 10.1016/0735-1097(91)90588-z.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Diffuse Long Coronary Artery Disease is Still an Obstacle for Percutaneous Coronary Intervention in the Second-Generation Drug-Eluting Stent Era?

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献